Aditya Kumar
Yale School of Medicine
Contributions made by B cell subsets to myasthenia gravis immune dysregulation

Aisling Carr
University College London
The neuropathy spectrum of Waldenström’s macroglobulinemia

Carolina Barnett-Tapia
University of Toronto
Health Utilities in Patients With Myasthenia Gravis

Chad Heatwole
University of Rochester Medical Center
Patient preferences on the use of three, patient-reported outcome measures of health in myotonic dystrophy type 1 PRISM-SMA: Patient Reported Impact of Symptoms in Adult Spinal Muscular Atrophy

Craig Campbell
London Health Science Centre
A Detailed Phenotypic Analysis of Congenital Myotonic Dystrophy using Phenostacks

Don McCorquodale
University of Utah
RNA-Seq gene expression profiling identifies up-regulation of novel muscle specific gene musclin in adult and congenital myotonic dystrophy

Donovan Lott
University of Florida
Magnetic Resonance Imaging and Functional Abilities in People with Myotonic Dystrophy Type 1

Elisa De Mattia
The NEMO Clinical Center, University of Milan
Validation of the Respiratory Symptom Checklist for patients with Myotonic Dystrophies: Preliminary Results

Emma Matthews
University College London
Improving early diagnosis in children with skeletal muscle channelopathies

Enrico Bugiardini
University College London
Next generation sequencing in inherited myopathies

Evan Pucillo
University of Utah
Falls and functional measures in adult-onset Myotonic Dystrophy type 1: A cross-sectional study

Gary Ingenito
Catalyst Pharmaceuticals
Clinical and Physiological Changes with Amifampridine Phosphate Treatment in Congenital Myasthenic Syndrome – Leading to a Controlled Trial

Gita Ramdharry
Kingston University/MRC Centre
Evaluating the benefits of community-based aerobic training on the physical health and well-being of people with Neuromuscular Disease

Iwona Skorupinska
University College London
Cause of death in a cohort of mitochondrial patients

Johanna Hamel
University of Rochester
Temporal and spatial evolution of stroke-like lesions on MRI in MELAS

Jonathan Goldstein
University of Rochester
A case of severe immune-mediated statin myopathy responsive to immunotherapy

John Yi
Duke University
Detection of AChR-Specific B Cells by Flow Cytometry

John Day
Stanford University
CK-2127107, a selective activator of the fast skeletal muscle troponin complex, for the potential treatment of Spinal Muscular Atrophy

Karen Sutterlin
University College London
Functional analysis of ClC-1 variants informs genetic counselling for Myotonia Congenita

Mario Saporta
University of Florida
Axonal RNA Profiling of Human Motor Neurons from Patients with Charcot-Marie-Tooth Disease as a Novel Approach to Study Axon Degeneration

Mariola Skorupinksa
University College London
Pregnancy in Patients with Charcot-Marie-Tooth Disease and Related Hereditary Neuropathies: Results of Survey

Mary Pautler
University of Utah
Limits of Postural Stability in Myotonic Dystrophy Compared to Normative Values

Natalie James
University College London
Pilot Study to explore pain experienced by patients with a skeletal muscle channelopathy

Noah Kolb
University of Vermont
Carefully Phenotyped Changes in Neuropathy Measures with Exposure to Neurotoxic Chemotherapy

Olivia Poole
University College London
TRIAP1 mutations are a cause of reversible infantile bulbar failure with subsequent progressive adolescent onset myopathy

Pam Van Ry
University of Nevada- Reno
Galectin-1 ameliorates disease pathology in two mouse models of Duchenne Muscular Dystrophy

Pedro Machado
University College London
Baseline characteristics of a prospective natural history study of sporadic inclusion body myositis including MRI assessment

Peter Creigh
University of Rochester
Clinical features of Andersen Tawil Syndrome in a patient with Thyrotoxic Periodic Paralysis

Qing Ke
Zhejiang University, China
Newborn screening for DMD in Hangzhou: Establishing the registry and follow up program

Riccardo Zuccarino
NEMO Clinical Centre, Fondazione Serena Onlus
Aerobic Exercise in Patients Affected by Charcot-Marie-Tooth Neuropathy: Results of a Randomized, Single Blind, Controlled Stud

Robert Pitceathly
University College London
RNASEH1 mutations are a rare cause of CPEO with multiple mtDNA deletions

Russell Butterfield
University of Utah
Meta-analyses of ataluren in patients with nonsense mutation Duchenne muscular dystrophy (nmDMD) Use of the Six-Minute Walk Distance (6MWD) Across Duchenne Muscular Dystrophy (DMD) Studies

Sarah Youssof
University of New Mexico
Patient-reported experience of dysphagia in OPMD: A qualitative study

Stanley Iyadurai
Ohio State University
Variable Phenotypes underlying Novel Congenital Myasthenic Syndrome Mutations: Presentation, Electrodiagnostic Characterizations, and Therapeutic Approaches

Summer Brown
University of Utah
The Clinical Phenotype and Neuropathic Outcomes of Paclitaxel-Acute Pain Syndrome

Timothy Walton
IVIG Treatments Related Fluctuations in CIDP Patients Using Daily Grip strength Measurements (GRIPPER): Study Design and Progress Update

W. David Arnold
Ohio State University
Open Label Trial of Ranolazine in Myotonia Congenita